Furthermore, an inverse correlation between ANRIL and p15 expression was discovered in patients with ALL and AML [31], suggesting an ANRIL-dependent regulation mechanism for p15 in leukemia. This evidence concerns the gene CDKN2B and acute lymphoblastic leukemia.